Jason Bassetti

Davis Polk advised Comcast Corporation and NBCUniversal Media, LLC in connection with their $5.5 billion exchange offer of new lower-coupon Comcast senior notes for seven series of Comcast…

Davis Polk is advising McKesson Corporation on its acquisition of RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health…

Davis Polk advised the underwriters in connection with an initial public offering of 4,983,333 shares of common stock of Sienna Biopharmaceuticals, Inc., including shares sold pursuant to…

Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 1,495,000 shares of common stock for an aggregate price to the public of approximately $113.62 million…

Davis Polk advised McKesson Corporation in connection with the offering of $1 billion aggregate principal amount of notes issued by Change Healthcare Holdings, LLC and Change Healthcare…

Davis Polk advised Inkling Systems, Inc. in connection with its $25 million Series E round of financing led by Sapphire Ventures. Founded in 2009, Inkling offers a mobile communication…

Davis Polk advised Ingram Micro Inc. on the completion of its $6 billion all-cash acquisition by Tianjin Tianhai Investment Company, Ltd., a part of HNA Group, which closed on December 5,…

Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will combine substantially all of Change Healthcare Holdings, Inc.’s…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. (“NuVasive”) of $650 million aggregate principal amount of its 2.25% convertible senior…

Davis Polk is advising Ingram Micro Inc. on its $6.0 billion all-cash acquisition by Tianjin Tianhai Investment Company, Ltd., a part of HNA Group. The transaction, which is expected to…